CDKN2A and exocrine pancreatic carcinoma: The fourth mutation was detected in a patient who had a pancreatic carcinoma in addition to cutaneous melanoma, and is characterised by a C>T substitution at nucleotide 170 that changes the p16INK4a reading frame (Ala57Val), whereas it is neutral for p14ARF (Arg71Arg; Table 3).